Shu Y - Search Results

1

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer.

Guo R, Chen X, Wang T, Zhang Z, Sun J, Shu Y. Guo R, et al. Among authors: shu y. BMC Cancer. 2011 Mar 2;11:90. doi: 10.1186/1471-2407-11-90. BMC Cancer. 2011. PMID: 21366910 Free PMC article.

2

Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells.

Wu H, Li W, Wang T, Shu Y, Liu P. Wu H, et al. Among authors: shu y. Biomed Pharmacother. 2008 Nov;62(9):659-66. doi: 10.1016/j.biopha.2008.08.002. Epub 2008 Aug 31. Biomed Pharmacother. 2008. PMID: 18809274

3

Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.

Guo R, Huang Z, Shu Y, Jin S, Ge H. Guo R, et al. Among authors: shu y. Biomed Pharmacother. 2009 Jun;63(5):375-9. doi: 10.1016/j.biopha.2008.09.010. Epub 2008 Oct 23. Biomed Pharmacother. 2009. PMID: 18993026

4

[Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells].

Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ. Guo RH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):745-8. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173802 Chinese.

5

CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.

Ju S, Qiu H, Zhou X, Zhu B, Lv X, Huang X, Li J, Zhang Y, Liu L, Ge Y, Johnson DE, Ju S, Shu Y. Ju S, et al. Among authors: shu y. Cell Cycle. 2009 Aug 15;8(16):2578-85. doi: 10.4161/cc.8.16.9302. Epub 2009 Aug 19. Cell Cycle. 2009. PMID: 19597336

6

Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

Guo R, Wang T, Shen H, Ge HM, Sun J, Huang ZH, Shu YQ. Guo R, et al. Biomed Pharmacother. 2010 Apr;64(4):249-53. doi: 10.1016/j.biopha.2009.06.007. Epub 2009 Oct 22. Biomed Pharmacother. 2010. PMID: 19931998

7

The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer.

Wang RS, Liu LX, Gu YH, Lin QF, Guo RH, Shu YQ. Wang RS, et al. Biomed Pharmacother. 2010 May;64(5):309-12. doi: 10.1016/j.biopha.2009.09.011. Epub 2009 Nov 5. Biomed Pharmacother. 2010. PMID: 19942398

8

Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects.

Shen H, Yuan Y, Sun J, Gao W, Shu YQ. Shen H, et al. Among authors: shu yq. Biomed Pharmacother. 2010 Feb;64(2):88-92. doi: 10.1016/j.biopha.2009.06.010. Epub 2009 Oct 23. Biomed Pharmacother. 2010. PMID: 20005069

9

Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance.

Shen L, Zhu Z, Huang Y, Shu Y, Sun M, Xu H, Zhang G, Guo R, Wei W, Wu W. Shen L, et al. Among authors: shu y. Biomed Pharmacother. 2010 May;64(5):313-8. doi: 10.1016/j.biopha.2009.12.003. Epub 2010 Jan 8. Biomed Pharmacother. 2010. PMID: 20106632

10

A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population.

Zhang M, Hu Z, Huang J, Shu Y, Dai J, Jin G, Tang R, Dong J, Chen Y, Xu L, Huang X, Shen H. Zhang M, et al. Among authors: shu y. Clin Cancer Res. 2010 Feb 15;16(4):1236-44. doi: 10.1158/1078-0432.CCR-09-2719. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,861 results

Search Page

Filters